These Regulations amend the Human Medicines Regulations 2012 (“the 2012 Regulations”), which govern the arrangements, across the United Kingdom, for the licensing, manufacture, wholesale dealing and sale or supply of human medicines for human use. The provisions in the 2012 Regulations to which the Note refers are presently due to cease to have effect on 1st April 2022.